The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
To ensure optimal results, consulting a medical professional is crucial to determine the best semaglutide formulation tailored to individual preferences and health goals
Potenza OB causes an increase in heart rate
4 WeightWatchers WeightWatchers is often described as the most studied commercial weight management programme in the world, with decades of research on its core programme
In fact, the cardiovascular benefits of weight loss typically outweigh the temporary heart rate elevation